New Neuron Atlas of the Striatum Could Inform Treatments for Brain Disorders
MIT researchers have developed a new atlas detailing the neurons in the brain's striatum, which is crucial for cognitive and motor functions. This atlas, identifying 31 subgroups of neurons, may guide the development of treatments for conditions such as Huntington's disease, schizophrenia, and substance use disorders. The findings highlight the potential for targeted therapies that could mitigate side effects of existing medications, offering hope for improved treatment strategies.
A new atlas of neurons in the brain's striatum has been created by researchers at MIT, potentially paving the way for innovative treatments for Huntington's disease, schizophrenia, and substance use disorders. The striatum plays a vital role in various cognitive and motor functions, including decision-making, movement control, habit formation, and reward processing. It is also significantly impacted by several neurological disorders. By employing advanced techniques such as single-cell RNA sequencing, the researchers identified 31 distinct subgroups of neurons based on their gene expression profiles, including those involved in addiction and mental health conditions.
One of the key findings of the study is the identification of specific neuron populations that are more susceptible to Huntington's disease. The researchers discovered that certain medium spiny neurons in the dorsal part of the striatum express higher levels of genes associated with the huntingtin gene, which is responsible for the disease. This insight could lead to the development of targeted therapies that enhance the resilience of other neurons against the disease's effects.
The research also revealed two unique populations of medium spiny neurons, known as D1 and D2 outliers, which are linked to addiction and depression. These populations showed significant gene expression related to opioid response and antidepressant activity. Understanding these subpopulations may help in designing drugs that can effectively treat schizophrenia without the severe side effects associated with current medications like clozapine.
In addition, the researchers compared human neuron samples with those from mice, uncovering species-specific differences in gene expression that could affect the modeling of substance use disorders. This comparison underscores the importance of developing more accurate rodent models that reflect human biology, particularly in the context of addiction research.
The atlas was constructed using contributions from brain donors and their families, representing a collaborative effort across institutions. The research was supported by various funding bodies, including the National Institutes of Health. The findings, published in the journal Cell, are expected to serve as a foundational resource for further studies aimed at developing new therapeutic strategies for challenging brain disorders.
